Cell & gene therapy has developed by leaps and bounds in recent years, providing the possibility for many refractory diseases. With the rapid development of gene transduction and modification technology, delivery vector system, cell culture technology and other technology, breakthroughs have been made in cell & gene therapy, providing a new treatment concept and train of thoughts. Medicilon's preclinical research services cover pharmacodynamic research, drug safety evaluation , pharmacokinetic research, bioanalysis, etc. The establishment of a complete gene therapy R&D platform can provide one-stop services for research on pharmacological efficacy, biodistribution and safety evaluation of cell and gene therapy products. Medicilon has established a one-stop research platform for the preclinical research and development of cellular immunotherapy drugs, covering a variety of immunotherapy methods including CAR-T, TCR-T, CAR-NK and TIL cells, etc. ...
Integrated Drug Discovery Services- Chemistry, Biology & Preclinical Services